Shenzhen Chipscreen Biosciences Coの収益Y / Y

Shenzhen Chipscreen Biosciences Coの収益Y / Yは何ですか。

Shenzhen Chipscreen Biosciences Co., Ltd.の収益Y / Yは5.15%です。

収益Y / Yの定義は何ですか。

過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

SSEのセクタHealth Careにおける収益Y / Yの企業と比べるShenzhen Chipscreen Biosciences Co

Shenzhen Chipscreen Biosciences Coは何をしますか。

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Shenzhen Chipscreen Biosciences Coと類似の収益y / y